A Multi-Center, Phase 2, Open-label Parallel Cohort Study of Efficacy and Safety of Duvelisib in Patients with Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)
Clinical Trial Grant
Awarded By
Secura Bio, Inc.
Start Date
February 18, 2020
End Date
February 14, 2025
Awarded By
Secura Bio, Inc.
Start Date
February 18, 2020
End Date
February 14, 2025